Feature|Articles|August 31, 2026

Agentic AI and the Administrative Backbone of Clinical Trials: Why the Operating Model Has to Change First

Agentic AI is arriving in clinical operations with genuine capability to absorb administrative work, but the organizations that will realize lasting value are those willing to redesign accountability structures, financial workflows, and operating models before deploying the tools on top of them.

Agentic artificial intelligence (AI) is not a future scenario in clinical development; it is already being deployed across invoice processing, site feasibility, patient sourcing, and financial workflow automation. However, the industry has a long history of acquiring new tools without changing the processes underneath them, and the structural gaps that have always limited clinical operations do not disappear when a new technology wave arrives.

Related to this article

Recruitment in the Age of AI: Q&A with John Worden, Javara
In this Q&A, John Worden, chief commercial officer at Javara, discusses why clinical trial recruitment has remained stubbornly one-size-fits-all, how AI can identify patients at scale without displacing the clinician relationships that drive trust, and what care-integrated research engagement needs to look like for health systems, sponsors, and sites.
© C Davids/peopleimages.com - © C Davids/peopleimages.com - stock.adobe.com
The clinical research industry talks about patient-centeredness constantly but embeds it too late, too narrowly, and without clear ownership, and the cost shows up in enrollment failures, protocol deviations, and outcomes that don't reflect what patients actually care about.